- MARIO-4 registration study in frontline metastatic triple negative breast cancer to be initiated by year end 2022 - - MARIO-P platform study in multiple solid tumors to be initiated on a rolling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback